Filing Details
- Accession Number:
- 0001209191-23-020477
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-22 16:01:41
- Reporting Period:
- 2023-03-20
- Accepted Time:
- 2023-03-22 16:01:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1566044 | Vyne Therapeutics Inc. | VYNE | Pharmaceutical Preparations (2834) | 453757789 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1727809 | Mutya Harsch | C/O Vyne Therapeutics Inc. 685 Route 202/206, Suite 301A Bridgewater NJ 08807 | Chief Legal Officer And Gc | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-03-20 | 10,000 | $2.50 | 22,721 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- On February 10, 2023, the Issuer effected a one-for-18 reverse split of its Common Stock. The number of securities reported reflects the reverse split.
Billionaire Hedge Funds
